Managing Obesity in Survivors of Gynecologic Cancer

Allison Staley, MD, MPH
Published: Saturday, May 25, 2019
Staley, MD, MPH

Allison Staley, MD, MPH

Obesity influences the development and management of gynecologic cancer through several mechanisms, including hormonal, inflammatory, and metabolic pathways. Prospective data demonstrate a significantly increased risk of mortality from cancers of the breast, uterus, cervix, and ovary in women who are considered obese.1 With nearly 40% of the adult population in the Unites States classified as obese (body mass index [BMI] ≥30kg/m2), gynecologic oncologists must be ready to address the specific needs and considerations for this population, including for patients who have entered survivorship.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Show Me the Data™: Leveraging Evidence to Optimize Applications of PARP Inhibitor Strategies in Ovarian CancerJun 29, 20191.5
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication